213 results on '"Hanania, Taleen"'
Search Results
2. D-cycloserine is not susceptible to self-administration using an intravenous self-administration model in male ketamine-habituated Sprague-Dawley rats
3. The high-affinity nAChR partial agonists varenicline and sazetidine-A exhibit reinforcing properties in rats
4. Elevation of brain magnesium with Swiss chard and buckwheat extracts in an animal model of reduced magnesium dietary intake
5. Reprint of: Highthroughtput analysis of behavior for drug discovery☆
6. High-throughput analysis of behavior for drug discovery
7. Pharmacological characterization of harmaline-induced tremor activity in mice
8. Anxiolytic effects of lamotrigine and JZP-4 in the elevated plus maze and in the four plate conflict test
9. Elevation of brain magnesium with Swiss chard and buckwheat extracts in an animal model of reduced magnesium dietary intake.
10. Dissociation between duration of action in the forced swim test in mice and nicotinic acetylcholine receptor occupancy with sazetidine, varenicline, and 5-I-A85380
11. Translational aspects of pharmacological research into anxiety disorders: The stress-induced hyperthermia (SIH) paradigm
12. Computational Analysis of Multidimensional Behavioral Alterations After Chronic Social Defeat Stress
13. Behavior-Based Screening as an Approach to Polypharmacological Ligands
14. Discriminative stimulus properties of GABAA receptor positive allosteric modulators TPA023, ocinaplon and NG2–73 in rats trained to discriminate chlordiazepoxide or zolpidem
15. Aβ-accelerated neurodegeneration caused by Alzheimer’s-associated ACE variant R1279Q is rescued by angiotensin system inhibition in mice
16. Mouse model systems of autism spectrum disorder: Replicability and informatics signature
17. The N-methyl-D-aspartate receptor antagonist d-methadone acutely improves depressive-like behavior in the forced swim test performance of rats.
18. Psychostimulant-like discriminative stimulus and locomotor sensitization properties of the wake-promoting agent modafinil in rodents
19. The modified Geller–Seifter test in rats was insensitive to GABAB receptor positive modulation or blockade, or 5-HT1A receptor activation
20. The nAChR agonist AMOP-H-OH (‘sazetidine-Aʼ) exhibits reinforcing, but not withdrawal-alleviating, properties in rats: 3.12
21. ANATOMY AND PHYSIOLOGY OF THE CENTRAL NERVOUS SYSTEM
22. In vivo pharmacological effects of JZP-4, a novel anticonvulsant, in models for anticonvulsant, antimania and antidepressant activity
23. Differential regulation of cocaine-induced locomotor activity in inbred long-sleep and short-sleep mice by dopamine and serotonin systems
24. Myelinated axons fail to develop properly in a genetically authentic mouse model of Charcot-Marie-Tooth disease type 2E
25. ANAVEX®2-73 (blarcamesine), a Sigma-1 receptor agonist, ameliorates neurologic impairments in a mouse model of Rett syndrome
26. SEP-363856, a Novel Psychotropic Agent with a Unique, Non-D2 Receptor Mechanism of Action
27. Mouse Model Systems of Autism Spectrum Disorder: Replicability and Informatics Signature
28. Biomarker Analysis of Orally Dosed, Dual Active, Matrix Metalloproteinase (MMP)-2 and MMP-9 Inhibitor, AQU-118, in the Spinal Nerve Ligation (SNL) Rat Model of Neuropathic Pain
29. Myelinated axons fail to develop properly in a genetically authentic mouse model of Charcot-Marie-Tooth disease type 2E
30. P1‐488: BEHAVIORAL MANIFESTATIONS, AGRESSION AND PLAQUE DISTRIBUTION IN TRANSGENIC MOUSE MODELS OF ALZHEIMER'S DISEASE
31. Effect of a novel, orally active matrix metalloproteinease-2 and-9 inhibitor in spinal and trigeminal rat models of neuropathic pain
32. Early life diet containing prebiotics and bioactive whey protein fractions increased dendritic spine density of rat hippocampal neurons
33. Comprehensive Analysis of Two Shank3 and the Cacna1c Mouse Models of Autism Spectrum Disorder
34. P4‐039: Differences between TG2576‐ and APP/PS1 Mice in High‐Throughput Behavioral Screening Correlates with Differences in Brain Pathology
35. P3-068: Effects of Treatment With Doxycycline on Behavior, Neuroinflammation and Brain Pathology in the RTG-4510 Mouse Model
36. In vivo phenotypic drug discovery: applying a behavioral assay to the discovery and optimization of novel antipsychotic agents
37. BEHAVIORAL MANIFESTATIONS, AGRESSION AND PLAQUE DISTRIBUTION IN TRANSGENIC MOUSE MODELS OF ALZHEIMER’S DISEASE
38. Comprehensive Analysis of the 16p11.2 Deletion and Null Cntnap2 Mouse Models of Autism Spectrum Disorder
39. Noribogaine reduces nicotine self-administration in rats
40. Dendritic Spine Density of Rat Hippocampal Neurons is Increased Following Consumption of Diet Containing a Prebiotic Blend and Bioactive Whey Protein Fractions
41. Characterization of Noribogaine at nAChRs and Effect on Nicotine Self‐Administration in Rats
42. Dietary prebiotics improve memory and social interactions while reducing anxiety when provided early in life to normally developing rodents (637.5)
43. The potent and selective α 4 β 2*/ α 6*‐nicotinic acetylcholine receptor partial agonist 2‐[5‐[5‐(( S )Azetidin‐2‐ylmethoxy)‐3‐pyridinyl]‐3‐isoxazolyl]ethanol demonstrates antidepressive‐like behavior in animal models and a favorable ADME‐tox profile
44. DIFFERENCES BETWEEN TG2576- AND APP/PS1 MICE IN HIGH-THROUGHPUT BEHAVIORAL SCREENING CORRELATES WITH DIFFERENCES IN BRAIN PATHOLOGY
45. EFFECTS OF TREATMENT WITH DOXYCYCLINE ON BEHAVIOR, NEUROINFLAMMATION AND BRAIN PATHOLOGY IN THE RTG-4510 MOUSE MODEL
46. SAHA Enhances Synaptic Function and Plasticity In Vitro but Has Limited Brain Availability In Vivo and Does Not Impact Cognition
47. Chemistry, Pharmacology, and Behavioral Studies Identify Chiral Cyclopropanes as Selective α4β2-Nicotinic Acetylcholine Receptor Partial Agonists Exhibiting an Antidepressant Profile. Part II
48. Characterization of Maleimide-Based Glycogen Synthase Kinase-3 (GSK-3) Inhibitors as Stimulators of Steroidogenesis
49. Discovery of Highly Potent and Selective α4β2-Nicotinic Acetylcholine Receptor (nAChR) Partial Agonists Containing an Isoxazolylpyridine Ether Scaffold that Demonstrate Antidepressant-like Activity. Part II
50. Insights into the Structural Determinants Required for High-Affinity Binding of Chiral Cyclopropane-Containing Ligands to α4β2-Nicotinic Acetylcholine Receptors: An Integrated Approach to Behaviorally Active Nicotinic Ligands
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.